NCT03598998 2025-06-26
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
City of Hope Medical Center
Phase 1/2 Active not recruiting
Clinical Trials
1 trialsOTHER × Subcutaneous panniculitis-like T-cell lymphoma × 10-propargyl-10-deazaaminopterin × Clear all